TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 110 filers reported holding TG THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,037 | -88.6% | 5,746 | -66.1% | 0.00% | -85.7% |
| Q2 2023 | $420,590 | +341843.1% | 16,932 | +108.1% | 0.01% | +250.0% |
| Q1 2023 | $123 | -74.9% | 8,135 | -80.4% | 0.00% | -80.0% |
| Q4 2022 | $490 | -99.8% | 41,449 | -24.0% | 0.02% | +300.0% |
| Q3 2022 | $323,000 | +262.9% | 54,538 | +161.3% | 0.01% | +150.0% |
| Q2 2022 | $89,000 | -36.4% | 20,872 | +41.4% | 0.00% | +100.0% |
| Q1 2022 | $140,000 | -34.9% | 14,763 | +30.4% | 0.00% | -75.0% |
| Q4 2021 | $215,000 | -14.7% | 11,325 | +49.9% | 0.00% | -33.3% |
| Q3 2021 | $252,000 | +154.5% | 7,555 | +197.2% | 0.01% | +100.0% |
| Q2 2021 | $99,000 | -81.8% | 2,542 | -77.4% | 0.00% | -66.7% |
| Q1 2021 | $543,000 | +46.4% | 11,256 | +57.8% | 0.01% | -18.2% |
| Q4 2020 | $371,000 | +381.8% | 7,131 | +148.6% | 0.01% | +1000.0% |
| Q3 2020 | $77,000 | -78.9% | 2,869 | -84.7% | 0.00% | -93.3% |
| Q2 2020 | $365,000 | +36400.0% | 18,702 | +18602.0% | 0.02% | – |
| Q4 2019 | $1,000 | -90.9% | 100 | -94.6% | 0.00% | -100.0% |
| Q3 2019 | $11,000 | -88.8% | 1,837 | -83.7% | 0.00% | -85.7% |
| Q2 2019 | $98,000 | +1860.0% | 11,275 | +798.4% | 0.01% | – |
| Q4 2018 | $5,000 | -89.6% | 1,255 | -85.2% | 0.00% | -100.0% |
| Q3 2018 | $48,000 | -32.4% | 8,468 | +56.0% | 0.00% | 0.0% |
| Q2 2018 | $71,000 | +91.9% | 5,427 | +106.6% | 0.00% | +33.3% |
| Q1 2018 | $37,000 | +1750.0% | 2,627 | +1052.2% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 228 | -56.7% | 0.00% | – |
| Q4 2016 | $2,000 | +100.0% | 527 | +204.6% | 0.00% | – |
| Q3 2016 | $1,000 | -95.8% | 173 | -95.5% | 0.00% | -100.0% |
| Q2 2016 | $24,000 | +166.7% | 3,882 | +277.3% | 0.00% | +100.0% |
| Q1 2016 | $9,000 | +12.5% | 1,029 | +45.8% | 0.00% | 0.0% |
| Q4 2015 | $8,000 | -85.2% | 706 | -86.8% | 0.00% | -80.0% |
| Q3 2015 | $54,000 | +237.5% | 5,349 | +467.8% | 0.01% | +400.0% |
| Q2 2015 | $16,000 | -85.7% | 942 | -87.0% | 0.00% | -92.9% |
| Q1 2015 | $112,000 | +194.7% | 7,250 | +198.7% | 0.01% | +250.0% |
| Q4 2014 | $38,000 | +22.6% | 2,427 | -17.9% | 0.00% | +33.3% |
| Q3 2014 | $31,000 | +287.5% | 2,957 | +269.2% | 0.00% | +200.0% |
| Q2 2014 | $8,000 | -46.7% | 801 | -63.1% | 0.00% | -50.0% |
| Q1 2014 | $15,000 | 0.0% | 2,170 | -28.5% | 0.00% | 0.0% |
| Q3 2013 | $15,000 | – | 3,037 | +4961.7% | 0.00% | – |
| Q2 2013 | $0 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |